COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD ZincZn
HC Q study #40
Source   PDF   Share   Tweet
See all 155 studies
5/19
Negative
Late treatment study
Singh et al., medRxiv, doi:10.1101/2020.05.12.20099028 (Preprint)
Outcomes of Hydroxych loroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network
EHR analysis of 3,372 hospitalized COVID-19 patients not showing a significant difference for mortality or the risk of mechanical ventilation. Subject to the limitations of EHR analysis. Misclassification is possible. Confounding by indication.
death, ↓5.0%, p=0.72
ventilation, ↓19.0%, p=0.26
Source   PDF   Share   Tweet
See all 155 studies
Please send us corrections, updates, or comments.
Submit